Study guide

7.5 Special Intrapartum Procedures: Amniotomy, Amnioinfusion, Cervical Ripening & Labor Augmentation

NCC Inpatient Obstetric Nursing RNC-OB

Track your progress as you read

Finished sections get a check mark.

1 Chapter 0: Introduction & How to Use This Guide

0.1 About the RNC-OB Credential & Exam Blueprint 0.2 How to Use This Study Guide & Clinical Learning Methodology

2 Chapter 1: Pregnancy Complications — Maternal Medical Conditions

1.1 Hypertensive Disorders of Pregnancy 1.2 HELLP Syndrome & Hepatic Disorders of Pregnancy 1.3 Diabetes Mellitus in Pregnancy 1.4 Maternal Cardiac and Respiratory Disorders 1.5 Infectious Diseases in Inpatient Obstetrics 1.6 Hematologic, Endocrine, Connective Tissue & Other Systemic Disorders

3 Chapter 2: Pregnancy Complications — Preterm Labor, Multiple Gestation, Placental & Fetal Disorders

2.1 Psychosocial Disorders, Substance Use & Environmental Exposures 2.2 Preterm Labor: Assessment, Tocolysis & Neuroprotection 2.3 Multiple Gestation: Placentation, Chorionicity & Complications 2.4 Placental Disorders: Previa, Abruption, Vasa Previa & PAS 2.5 Fetal Growth Disorders & Amniotic Fluid Complications

4 Chapter 3: Antenatal Fetal Assessment & Surveillance

3.1 Antenatal Testing Methods & Indications for Fetal Surveillance 3.2 Nonstress Test (NST), Contraction Stress Test (CST) & Biophysical Profile (BPP) 3.3 Diagnostic Prenatal Procedures (Amniocentesis, CVS, PUBS, cfDNA & Ultrasound) 3.4 Fetal Oxygenation Physiology & Acid-Base Regulation 3.5 Umbilical Cord Blood Gas Collection & Clinical Interpretation

5 Chapter 4: Fetal Assessment & Electronic Fetal Monitoring (EFM)

4.1 NICHD Electronic Fetal Monitoring Terminology & Baseline Features 4.2 FHR Decelerations, Acceleration Patterns & Uterine Activity 4.3 The NICHD Three-Tier Fetal Heart Rate Classification System 4.4 Intrauterine Resuscitation & Clinical Action Protocols 4.5 Fetal Arrhythmias, Dysrhythmias & Artifact Differentiation

6 Chapter 5: Labor & Birth Physiology — Mechanics, Cardinal Movements, Stages & Support

5.1 Physiology of Labor & Uterine Mechanics 5.2 Pelvic Anatomy, Fetal Lie, Presentation & Cardinal Movements of Labor 5.3 Stages of Labor, Cervical Dilatation Dynamics & Progression Guidelines 5.4 Intrapartum Admission Assessment, Obstetric Triage & Membrane Rupture Evaluation 5.5 Labor Support, Non-Pharmacologic Pain Management & Physiologic Birth Practices

7 Chapter 6: Labor & Birth Interventions — Cervical Ripening, Induction, Pain Management & Anesthesia

6.1 Bishop Scoring, Pre-Induction Cervical Ripening & Mechanical Methods 6.2 Oxytocin Administration, Titration Protocols & Uterine Tachysystole Management 6.3 Nonpharmacologic Comfort & Labor Pain Management Strategies 6.4 Systemic Opioid Analgesia & Inhaled Nitrous Oxide 6.5 Neuraxial Analgesia, Spinal/Epidural Complications & General Anesthesia

8 Chapter 7: Labor & Birth — Operative Deliveries, TOLAC/VBAC & Special Intrapartum Procedures

7.1 External Cephalic Version (ECV) & Malpresentation Management 7.2 Operative Vaginal Delivery: Vacuum Extraction & Forceps-Assisted Birth 7.3 Cesarean Delivery: Surgical Indications, Intraoperative Management & PACU Recovery 7.4 Trial of Labor After Cesarean (TOLAC) & Vaginal Birth After Cesarean (VBAC) 7.5 Special Intrapartum Procedures: Amniotomy, Amnioinfusion, Cervical Ripening & Labor Augmentation

9 Chapter 8: Obstetric Emergencies & Critical Care

8.1 Shoulder Dystocia Management & HELPERR Protocol 8.2 Umbilical Cord Prolapse & Feto-Vascular Emergencies 8.3 Uterine Rupture & Acute Uterine Inversion 8.4 Amniotic Fluid Embolism (Anaphylactoid Syndrome of Pregnancy) 8.5 Intraamniotic Infection (Chorioamnionitis) & Maternal Sepsis

10 Chapter 9: Postpartum Physiology & Immediate Recovery Care

9.1 Postpartum Physiologic Changes & Maternal Systemic Adaptations 9.2 Fourth Stage of Labor & Immediate Recovery Care 9.3 Routine Postpartum Nursing Assessment & Clinical Care (BUBBLE-HE) 9.4 Rh Isoimmunization, Alloimmunization & Postpartum Immunizations 9.5 Postpartum Discharge Teaching, Warning Signs & Maternal Safety

11 Chapter 10: Postpartum Adaptation, Hemorrhage & Clinical Complications

10.1 Postpartum Hemorrhage: Definition, Risk Stratification, 4 Ts, QBL & Pharmacotherapy 10.2 Postpartum Infections: Endometritis, Wound Infections, Sepsis & Postpartum Pyrexia 10.3 Thromboembolic Disorders: DVT, Pulmonary Embolism & Septic Pelvic Thrombophlebitis 10.4 Perinatal Mood & Anxiety Disorders: Postpartum Blues, PPD, Anxiety & Postpartum Psychosis 10.5 Lactation Physiology, Breastfeeding Complications, Engorgement & Medication Safety

12 Chapter 11: Newborn Care, Transition & Clinical Assessment

11.1 Neonatal Physiologic Transition & Cardiorespiratory Adaptation 11.2 Immediate Newborn Care, Apgar Scoring & Delivery Room Stabilization 11.3 Newborn Thermoregulation & Pathophysiology of Cold Stress 11.4 Gestational Age & Neonatal Growth Assessment 11.5 Comprehensive Newborn Head-to-Toe Examination & Normal Variants

13 Chapter 12: Newborn Complications, Resuscitation & High-Acuity Management

12.1 Neonatal Resuscitation Program (NRP 8th Edition) & Delivery Room Resuscitation 12.2 Neonatal Glucose Homeostasis, Hypoglycemia Screening & Clinical Management 12.3 Neonatal Hyperbilirubinemia, Bilirubin Metabolism & Phototherapy Protocols 12.4 Neonatal Respiratory Distress: TTN, RDS, Meconium Aspiration & Persistent Pulmonary Hypertension (PPHN) 12.5 Neonatal Sepsis, Congenital Infections & Neonatal Abstinence Syndrome (NAS/NOWS)

14 Chapter 13: Professional Practice, Legal-Ethical Frameworks, Patient Safety & Quality Improvement

13.1 Legal Aspects of Perinatal Nursing & High-Risk Documentation Standards 13.2 Ethical Principles in Perinatal Care & Maternal-Fetal Conflicts 13.3 Quality Improvement, Perinatal Safety Initiatives & AIM Bundles 13.4 Patient Safety Culture, Team Communication & Clinical Escalation 13.5 Evidence-Based Practice, Research Utilization & Perinatal Guidelines

7.5 Special Intrapartum Procedures: Amniotomy, Amnioinfusion, Cervical Ripening & Labor Augmentation

Key Takeaways Explain This Topic AI

Amniotomy (Artificial Rupture of Membranes - AROM) is indicated for labor induction or augmentation and internal monitor placement; mandatory prerequisites require an engaged fetal vertex (station ≥0, ideally +1) to prevent acute umbilical cord prolapse.

The immediate, priority nursing action following any amniotomy is continuous auscultation or electronic monitoring of the Fetal Heart Rate (FHR) for at least one full minute, followed by assessing amniotic fluid color, odor, clarity, and quantity, and monitoring maternal temperature every 2 hours.

Amnioinfusion is the transcervical infusion of room-temperature or warmed isotonic crystalloid (Normal Saline or Lactated Ringer's) via an IUPC indicated to relieve recurrent variable decelerations caused by cord compression; routine amnioinfusion for meconium-stained fluid is no longer recommended.

Amnioinfusion safety requires continuous monitoring of uterine resting tone via IUPC (<15–20 mmHg) and verification of active vaginal fluid return on underpads to prevent polyhydramnios, uterine over-distension, and uterine rupture.

Labor induction with Oxytocin requires precise IV piggyback titration via an infusion pump connected to the primary line at the lowest proximal port; uterine tachysystole (>5 contractions in 10 minutes averaged over 30 minutes) mandates immediate stepwise intrauterine resuscitation.

Last updated: August 2026

Amniotomy (Artificial Rupture of Membranes - AROM)

Amniotomy (Artificial Rupture of Membranes - AROM) is the intentional surgical rupture of the chorioamniotic sac using a specialized sterile instrument (such as an AmniHook or Amnicot). Amniotomy is one of the most commonly performed intrapartum procedures, indicated to induce labor, augment protracted active labor, facilitate internal electronic fetal monitoring (placement of a Fetal Spiral Electrode [FSE] or Intrauterine Pressure Catheter [IUPC]), or visually evaluate amniotic fluid characteristics (meconium or blood). +-------------------------------------------------------------------------------------------------------------------+

| AMNIOTOMY CLINICAL SAFETY & EXECUTION PATHWAY |

+-------------------------------------------------------------------------------------------------------------------+

  • │
  • [ PRE-PROCEDURAL SAFETY VERIFICATION ]
  • Confirm Vertex Presentation & Engagement (Station >=0, ideally +1)
  • Verify Reactive FHR Baseline (Category I Tracing)
  • Rule out Vasa Previa, Placenta Previa, & Cord Presentation
  • Rule out Active Genital Infections (HIV, Active HSV, Untreated Hep B/C)
  • │
  • ▼
  • [ PROCEDURAL EXECUTION (AROM) ]
  • Sterile digital vaginal examination
  • Guide AmniHook along examining fingers
  • Snag and gently tear chorioamniotic membrane during/between contractions
  • Maintain finger in place to slowly release fluid and confirm head position
  • │
  • ▼
  • [ IMMEDIATE PRIORITY NURSING ACTIONS ]
  • ┌────────────────────────────────┴────────────────────────────────┐
  • ▼ ▼
  • [ 1. IMMEDIATE FHR ASSESSMENT ] [ 2. FLUID & MATERNAL ASSESSMENT ]
  • Auscultate / Monitor FHR for >=1 FULL MINUTE • Color: Clear, Pale Straw, Green, Port-Wine
  • Rule out Umbilical Cord Prolapse / Compression • Odor: Odorless vs Foul / Purulent (Infection)
  • Identify Variable Decelerations or Sudden Bradycardia • Amount: Scant, Moderate, Copious
  • │ │
  • └────────────────────────────────┬────────────────────────────────┘
  • │
  • ▼
  • [ ONGOING POST-RUPTURE SURVEILLANCE ]
  • Monitor MATERNAL TEMPERATURE EVERY 2 HOURS (Every 1h if >=38.0°C)
  • Limit digital vaginal examinations to minimize ascending infection
  • Maintain clean, dry underpads (perineal care)
  • Clinical Prerequisites & Contraindications to Amniotomy

Mandatory Prerequisite: Fetal Head Engagement (Station >=0): The fetal presenting part must be well-engaged against the cervix. If amniotomy is performed while the fetal head is high, unengaged, or floating (station -2 to -3), the sudden gush of amniotic fluid can carry the umbilical cord past the fetal head through the cervix, causing an acute umbilical cord prolapse .

Absolute Contraindications: Vasa previa or placenta previa (causes fatal fetal exsanguination); active primary genital herpes simplex virus (HSV) infection or high maternal HIV viral load (increases vertical transmission); unstable malpresentations (transverse lie, floating footling breech).

Characterization of Amniotic Fluid & Clinical Implications

Clear / Straw-Colored (Normal): Physiologic amniotic fluid containing vernix particles.

Green / Meconium-Stained: Indicates fetal passage of meconium in utero. May reflect physiologic gastrointestinal maturation in post-term fetuses, or transient/prolonged fetal hypoxic stress triggering vagal-mediated anal sphincter relaxation. Mandates immediate notification of the neonatal resuscitation team to be present at delivery.

Port-Wine / Frank Blood: Suggests acute placental abruption ( abruptio placentae ). Evaluate for uterine hypertonus, continuous pain, and fetal decelerations.

Foul-Smelling / Cloudy / Purulent: Diagnostic of intra-amniotic infection (chorioamnionitis / triple I) . Initiate broad-spectrum IV antibiotics (Ampicillin + Gentamicin) and frequent maternal-fetal monitoring.

Amnioinfusion: Indications, Mechanics & Fluid Surveillance

Amnioinfusion is the transcervical instillation of room-temperature or warmed sterile isotonic crystalloid (0.9% Normal Saline or Lactated Ringer's solution) into the amniotic cavity via an Intrauterine Pressure Catheter (IUPC). +-------------------------------------------------------------------------------------------------------------------+

| AMNIOINFUSION INDICATIONS & CONTRAINDICATIONS |

+-------------------------------------------------------------------------------------------------------------------+

  • EVIDENCE-BASED INDICATIONS PRACTICE CHANGES & CONTRAINDICATIONS
  • ------------------------------------------------- --------------------------------------------------
  • Relief of Recurrent, Deep VARIABLE DECELERATIONS • Routine Amnioinfusion for Meconium-Stained Fluid
  • secondary to umbilical cord compression IS NO LONGER RECOMMENDED by ACOG, AAP, or NRP

(common in oligohydramnios or post-rupture). (Does not reduce MAS, NICU admissions, or death).

  • Prophylactic infusion in known severe • Contraindicated in: Uterine Infection (Chorioamnionitis),
  • oligohydramnios during labor. Placenta Previa / Abruption, Non-Reassuring Fetal Tracing

requiring immediate delivery, Multiple Gestation.

+-------------------------------------------------------------------------------------------------------------------+ +-------------------------------------------------------------------------------------------------------------------+

| AMNIOINFUSION ADMINISTRATION & SAFETY PROTOCOL |

+-------------------------------------------------------------------------------------------------------------------+

[ 1. INFUSION PROTOCOL ]

  • Bolus Phase: 250 to 500 mL of isotonic crystalloid infused via infusion pump or gravity over 20 to 30 minutes.

• Maintenance Phase: Continuous infusion at 2 to 3 mL/minute (120 to 180 mL/hour), or intermittent boluses

(250 mL every 4 hours) guided by resolution of variable decelerations.

[ 2. FLUID RETURN SURVEILLANCE (The Primary Safety Check) ]

  • The nurse must continuously assess and verify ACTIVE VAGINAL FLUID RETURN on absorbent underpads.
  • If fluid is infused without corresponding vaginal outflow, fluid accumulates pathologically in the uterus.

[ 3. UTERINE RESTING TONE SURVEILLANCE VIA IUPC ]

  • Baseline resting tone must remain normal (5 to 15 mmHg, strictly <20 mmHg).
  • If resting tone climbs >20 to 25 mmHg or baseline fails to return between contractions -> STOP INFUSION IMMEDIATELY.
  • Elevated resting tone indicates FLUID ENTRAPMENT & OVER-DISTENSION, risking uterine rupture and abruption.

[ 4. FLUID TEMPERATURE REGULATION ]

  • Infuse room-temperature crystalloid for routine maintenance.
  • Use an in-line fluid warmer if infusing large volumes rapidly to prevent maternal-fetal hypothermia.

+-------------------------------------------------------------------------------------------------------------------+

Cervical Ripening: Mechanical & Pharmacologic Modalities

When labor induction is indicated in a patient with an unfavorable cervix, cervical ripening must precede oxytocin administration to increase vaginal delivery success and reduce cesarean rates. Pre-induction readiness is quantified using the Bishop Score : +-------------------------------------------------------------------------------------------------------------------+

| THE STANDARDIZED BISHOP SCORING SYSTEM |

+-------------------------------------------------------------------------------------------------------------------+

  • CERVICAL FACTOR SCORE 0 SCORE 1 SCORE 2 SCORE 3
  • ---------------------- -------------------- -------------------- -------------------- --------------------
  • DILATATION (cm) Closed (0 cm) 1 to 2 cm 3 to 4 cm >=5 cm
  • EFFACEMENT (%) 0% to 30% 40% to 50% 60% to 70% >=80%
  • STATION (cm) -3 cm -2 cm -1 to 0 cm +1 to +2 cm
  • CONSISTENCY Firm Medium Soft ---
  • CERVICAL POSITION Posterior Mid-position Anterior ---

CLINICAL INTERPRETATION:

• Bishop Score >=8: Favorable cervix (likelihood of successful vaginal delivery similar to spontaneous labor).

• Bishop Score <=6: Unfavorable cervix (mandates cervical ripening prior to oxytocin induction).

+-------------------------------------------------------------------------------------------------------------------+

Clinical Comparison of Cervical Ripening Methods

Ripening Modality Mechanism of Action Dosage & Route Oxytocin Delay Requirement Clinical Advantages & Safety Precautions

Transcervical Balloon (Foley / Cook) Mechanical dilation of internal os + endogenous prostaglandin release from decidual separation 16–18 Fr Foley with 30–60 mL sterile water in balloon; or double-balloon (Cook) Oxytocin can be started concurrently or immediately upon expulsion Safest method for TOLAC/scarred uterus; lowest rate of uterine tachysystole; low cost; expelled at ~3 cm.

Misoprostol (Cytotec / PGE1) Synthetic prostaglandin E1 analogue; dissolves cervical collagen, softens cervix, stimulates contractions 25 mcg orally or intravaginally every 3 to 6 hours (Max 50 mcg single dose) Must wait >=4 hours after last dose before starting oxytocin STRICTLY CONTRAINDICATED in prior cesarean / uterine scar; high risk of tachysystole; monitor EFM continuously.

Dinoprostone Insert (Cervidil / PGE2) Controlled-release prostaglandin E2 matrix; stimulates cervical collagenase and myometrial FP receptors 10 mg vaginal insert with retrieval string; continuous release at 0.3 mg/hr over 12 hrs Must wait 30 to 60 minutes after removal before starting oxytocin Removable string allows rapid withdrawal if tachysystole or non-reassuring FHR occurs; avoid in scarred uterus.

Dinoprostone Gel (Prepidil / PGE2) Prostaglandin E2 endocervical gel 0.5 mg intracervical gel via syringe applicator q6h (max 3 doses/24h) Must wait 6 to 12 hours after last dose before starting oxytocin Cannot be rapidly retrieved once instilled; monitor EFM for >=2 hours post-dose.

Labor Induction & Augmentation with Oxytocin (Pitocin)

Oxytocin (Pitocin) is a synthetic nonapeptide identical to the endogenous hormone synthesized in the maternal hypothalamus and released from the posterior pituitary. It is the gold-standard uterotonic agent for labor induction (initiating contractions before spontaneous onset) and labor augmentation (increasing frequency, duration, and intensity of inadequate spontaneous contractions). +-------------------------------------------------------------------------------------------------------------------+

| PHARMACOKINETICS & LINE CONNECTION SAFETY FOR OXYTOCIN |

+-------------------------------------------------------------------------------------------------------------------+

PHARMACOKINETIC PROFILE:

  • Route: Intravenous Infusion (Piggyback onto primary isotonic crystalloid line)
  • Onset of Action: Almost immediate (1 to 2 minutes IV)
  • Plasma Half-Life: 10 to 12 minutes
  • Time to Steady-State Plasma Concentration: 30 to 40 minutes (guides titration intervals)
  • Metabolism: Rapidly cleared by hepatic and renal oxytocinases

MANDATORY IV SETUP & INFUSION SAFETY:

• Oxytocin MUST ALWAYS be administered via a SMART INFUSION PUMP with dose error reduction systems.

• Oxytocin MUST ALWAYS be connected as a PIGGYBACK to the PROXIMAL (LOWEST) INJECTION PORT on the primary

IV tubing closest to the patient's vascular insertion site.

• Prevents large bolus of residual oxytocin from being inadvertently flushed into the patient if the primary

IV line rate is increased or bolused.

+-------------------------------------------------------------------------------------------------------------------+

Standard Dosing Protocols: Low-Dose vs. High-Dose Regimens +-------------------------------------------------------------------------------------------------------------------+

| OXYTOCIN TITRATION REGIMENS IN CONTEMPORARY PRACTICE |

+-------------------------------------------------------------------------------------------------------------------+

REGIMEN TYPE INITIAL DOSE INCREMENTAL INCREASE DOSING INTERVAL PRIMARY CLINICAL BENEFIT

---------------------- ---------------------- ---------------------- ------------------- ----------------------

  • LOW-DOSE REGIMEN 0.5 to 2 mU/min 1 to 2 mU/min Every 15 to 30 min Lower tachysystole rate;
  • (Standard / Conservative) safer in TOLAC & parity

---------------------- ---------------------- ---------------------- ------------------- ----------------------

  • HIGH-DOSE REGIMEN 4 to 6 mU/min 4 to 6 mU/min Every 15 to 30 min Shortens labor duration;
  • (Active Management) higher tachysystole risk

+-------------------------------------------------------------------------------------------------------------------+

Clinical Goals of Oxytocin Titration

Contraction Frequency: Every 2 to 3 minutes (maximum 5 contractions in a 10-minute window averaged over 30 minutes).

Contraction Duration: 40 to 90 seconds.

Contraction Intensity: Moderate to strong on palpation, or 40 to 80 mmHg peak pressure on IUPC ( 200 to 250 Montevideo Units [MVUs] in active labor).

Resting Tone: Soft uterine fundus between contractions, or 5 to 15 mmHg baseline on IUPC, with a minimum of 60 seconds of relaxation between contraction cycles to ensure placental oxygen reperfusion.

Uterine Tachysystole: Definition & Resuscitation Protocol +-------------------------------------------------------------------------------------------------------------------+

| UTERINE TACHYSYSTOLE MANAGEMENT PROTOCOL |

+-------------------------------------------------------------------------------------------------------------------+

DEFINITION: More than 5 uterine contractions in 10 minutes, averaged over a 30-minute window.

(Applies to both spontaneous and stimulated labor; clinical term replaces "hyperstimulation" and "hypertonus").

STEPWISE CLINICAL MANAGEMENT ALGORITHM:

[ SCENARIO A: TACHYSYSTOLE WITH CATEGORY I (NORMAL) FHR TRACING ]

1. Lateral repositioning (left or right lateral).

2. Administer IV crystalloid fluid bolus (500 mL Lactated Ringer's).

3. If tachysystole persists >10-15 minutes, DECREASE OXYTOCIN DOSE BY 50%.

4. If tachysystole persists >20-30 minutes, DISCONTINUE OXYTOCIN INFUSION.

[ SCENARIO B: TACHYSYSTOLE WITH CATEGORY II OR III (ABNORMAL) FHR TRACING ]

1. DISCONTINUE OXYTOCIN INFUSION IMMEDIATELY (Stop infusion, do not just reduce).

2. Turn patient to full LATERAL POSITION to maximize uteroplacental blood flow.

3. Administer rapid IV CRYSTALLOID BOLUS (500 to 1,000 mL Lactated Ringer's).

4. Administer SUPPLEMENTAL OXYGEN at 10 L/min via Non-Rebreather Mask if hypoxemia/decompensation is suspected.

5. If tachysystole and decelerations persist despite above measures:

-> Administer TOCOLYTIC: TERBUTALINE 0.25 mg SUBCUTANEOUSLY.

6. Notify attending obstetric provider and prepare for surgical intervention if Category III persists.

RE-STARTING OXYTOCIN AFTER TACHYSYSTOLE RESOLUTION:

• If discontinued <20-30 minutes: Resume at HALF THE PREVIOUS DOSE once Category I tracing is restored.

• If discontinued >30-40 minutes: Restart at INITIAL STARTING DOSE (1 to 2 mU/min).

+-------------------------------------------------------------------------------------------------------------------+

Critical Complication: Oxytocin Water Intoxication

Oxytocin possesses structural homology to arginine vasopressin (Antidiuretic Hormone [ADH]) . Prolonged administration of high-dose oxytocin (>20 to 40 mU/min), especially when infused in large volumes of hypotonic electrolyte-free IV fluids (e.g., 5% Dextrose in Water [D5W]), exerts a potent antidiuretic effect on renal practical tubules. This leads to water intoxication, profound dilutional hyponatremia (<125 mEq/L), acute cerebral edema, maternal seizures, coma, and maternal mortality . Inpatient obstetric nurses must infuse oxytocin only in isotonic crystalloids (Normal Saline or Lactated Ringer's) and maintain strict intake and output surveillance.